Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.81

-0.72

-0.63

-0.54

Details

Expected EPS

-0.754998

Actual EPS

-0.81

Surprise EPS

-0.06

Surprise Percent

+7.29%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.81 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.